PE-backed Kastle hires business development VC and chief legal counsel
Kastle Therapeutics, which is backed by Flexpoint Ford, has named Michael Shih as vice president of business development and chief legal counsel. Previously, Shih worked at Epizyme Inc where he served as vice president of business development. Based in Chicago, Kastle is a biopharmaceutical company focused on developing drugs for diseases with "high unmet medical needs."



